Aberdare Ventures II, L.P. - Net Worth and Insider Trading
Aberdare Ventures II, L.P. Net Worth
The estimated net worth of Aberdare Ventures II, L.P. is at least $17 Million dollars as of 2025-01-01. Aberdare Ventures II, L.P. is the 10% Owner of Anacor Pharmaceuticals Inc and owns about 1,751,936 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $17 Million. Details can be seen in Aberdare Ventures II, L.P.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aberdare Ventures II, L.P. has not made any transactions after 2010-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aberdare Ventures II, L.P.
Aberdare Ventures II, L.P. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aberdare Ventures II, L.P. owns 2 companies in total, including Reshape Lifesciences Inc (RSLS) , and Anacor Pharmaceuticals Inc (ANAC) .
Click here to see the complete history of Aberdare Ventures II, L.P.’s form 4 insider trades.
Insider Ownership Summary of Aberdare Ventures II, L.P.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RSLS | Reshape Lifesciences Inc | 2010-12-14 | other: Former 10% stockholder |
| ANAC | Anacor Pharmaceuticals Inc | 2010-11-30 | 10 percent owner |
Aberdare Ventures II, L.P. Latest Holdings Summary
Aberdare Ventures II, L.P. currently owns a total of 1 stock. Aberdare Ventures II, L.P. owns 1,751,936 shares of Anacor Pharmaceuticals Inc (ANAC) as of November 30, 2010, with a value of $17 Million.
Latest Holdings of Aberdare Ventures II, L.P.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAC | Anacor Pharmaceuticals Inc | 2010-11-30 | 1,751,936 | 9.82 | 17,204,012 |
Holding Weightings of Aberdare Ventures II, L.P.
Aberdare Ventures II, L.P. Form 4 Trading Tracker
According to the SEC Form 4 filings, Aberdare Ventures II, L.P. has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the acquisition of 300,000 shares on November 30, 2010, which cost Aberdare Ventures II, L.P. around $2 Million.
Insider Trading History of Aberdare Ventures II, L.P.
- 1
Aberdare Ventures II, L.P. Trading Performance
GuruFocus tracks the stock performance after each of Aberdare Ventures II, L.P.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aberdare Ventures II, L.P. is 57.8%. GuruFocus also compares Aberdare Ventures II, L.P.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Aberdare Ventures II, L.P. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aberdare Ventures II, L.P.'s insider trading performs compared to the benchmark.
Performance of Aberdare Ventures II, L.P.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4 | | | | | |
| Relative Return to S&P 500(%) | -2.55 | | | | | |
Aberdare Ventures II, L.P. Ownership Network
Aberdare Ventures II, L.P. Owned Company Details
What does Reshape Lifesciences Inc do?
Who are the key executives at Reshape Lifesciences Inc?
Aberdare Ventures II, L.P. is the other: Former 10% stockholder of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .
Reshape Lifesciences Inc (RSLS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reshape Lifesciences Inc Insider Transactions
Aberdare Ventures II, L.P. Mailing Address
Above is the net worth, insider trading, and ownership report for Aberdare Ventures II, L.P.. You might contact Aberdare Ventures II, L.P. via mailing address: One Embarcadero Center Suite 4000 San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
